Coherus Oncology Ownership | Who Owns Coherus Oncology?
Coherus Oncology Ownership Summary
Coherus Oncology is owned by 48.85% institutional investors, 18.54% insiders, and 32.61% retail investors. Blackrock is the largest institutional shareholder, holding 10.42% of CHRS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.96% of its assets in Coherus Oncology shares.
CHRS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Coherus Oncology | 48.85% | 18.54% | 32.61% |
| Sector | Healthcare Stocks | 35.74% | 11.83% | 52.43% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 11.75M | 10.42% | $20.33M |
| Vanguard group | 10.03M | 8.63% | $14.24M |
| Blackrock funding, inc. /de | 10.37M | 8.61% | $17.52M |
| Samsara biocapital | 3.43M | 2.85% | $5.79M |
| Geode capital management | 3.12M | 2.59% | $5.28M |
| Kohlberg kravis roberts | 3.04M | 2.52% | $5.07M |
| State street | 2.33M | 1.93% | $3.93M |
| Two sigma investments, lp | 2.30M | 1.91% | $3.89M |
| Alyeska investment group | 2.25M | 1.87% | $3.80M |
| Cm management | 2.10M | 1.74% | $3.55M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cm management | 2.10M | 2.97% | $3.55M |
| Propel bio management | 1.42M | 1.52% | $2.41M |
| Samsara biocapital | 3.43M | 0.56% | $5.79M |
| Tang capital management | 1.89M | 0.16% | $3.19M |
| Kohlberg kravis roberts | 3.04M | 0.09% | $5.07M |
| Dauntless investment group | 76.09K | 0.09% | $128.59K |
| C worldwide group | 1.93M | 0.07% | $3.26M |
| Tyche wealth partners | 240.87K | 0.06% | $407.07K |
| Eam investors | 309.80K | 0.06% | $523.56K |
| Gsa capital partners llp | 319.65K | 0.03% | $540.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Samsara biocapital | 3.43M | 0.56% | 3.43M |
| Alyeska investment group | 2.25M | 0.01% | 2.25M |
| Two sigma investments, lp | 2.30M | 0.00% | 1.80M |
| Propel bio management | 1.42M | 1.52% | 1.42M |
| Jacobs levy equity management | 1.00M | 0.01% | 1.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Temasek (private) | - | - | -5.82M |
| Point72 asset management | - | - | -5.28M |
| Bank of america corp /de/ | 275.10K | - | -2.15M |
| Macquarie group | - | - | -900.00K |
| Rubric capital management lp | - | - | -867.80K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Samsara biocapital | 3.43M | 0.56% | 3.43M | $5.79M |
| Alyeska investment group | 2.25M | 0.01% | 2.25M | $3.80M |
| Propel bio management | 1.42M | 1.52% | 1.42M | $2.41M |
| Vanguard fiduciary trust | 949.92K | 0.00% | 949.92K | $1.61M |
| Norges bank | 491.50K | 0.00% | 491.50K | $850.29K |
Sold Out
| Holder | Change |
|---|---|
| Eagle bay advisors | -30.00 |
| Nelson, van denburg & campbell wealth management group | -31.00 |
| Cornerstone planning group | -49.00 |
| Newbridge financial services group | -79.00 |
| Harbour investments | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 155 | 21.09% | 58,795,690 | 14.78% | 48 | 2.51% | 87 | 38.10% | 35 | 6.06% |
| Dec 31, 2025 | 78 | -34.45% | 37,433,194 | -27.54% | 32 | 1.63% | 37 | -32.73% | 19 | -42.42% |
| Sep 30, 2025 | 58 | -48.67% | 31,871,888 | -42.43% | 27 | 1.21% | 22 | -51.11% | 21 | -41.67% |
| Jun 30, 2025 | 113 | -4.24% | 55,361,532 | -10.83% | 47 | 1.66% | 46 | -6.12% | 35 | - |
| Mar 31, 2025 | 117 | -7.14% | 61,758,313 | -5.38% | 53 | 1.66% | 50 | -18.03% | 34 | 6.25% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 3.43M | 2.96% | - |
| HBM Healthcare Investments AG Ord | 3.71M | 2.41% | 3.71M |
| Vanguard Total Stock Mkt Idx Inv | 3.63M | 2.35% | - |
| iShares Russell 2000 ETF | 2.40M | 1.55% | 20.21K |
| C WorldWide Healthcare Select 1A | 1.93M | 1.29% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.69M | 1.10% | - |
| Vanguard Strategic Equity Inv | 1.58M | 1.06% | - |
| Vanguard Explorer Inv | 1.57M | 1.05% | - |
| AlphaCentric LifeSci Healthcare I | 1.00M | 0.87% | - |
| Delaware Healthcare I | 900.00K | 0.78% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 23, 2025 | Wahlstrom Mats | - | Sell | $73.88K |
| Nov 22, 2023 | Lanfear Dennis M | President & CEO | Sell | $449.77K |
| Oct 15, 2021 | Stilwell McDavid | Chief Financial Officer | Sell | $58.92K |
| Sep 28, 2021 | HEALY JAMES | - | Sell | $829.81K |
| Sep 27, 2021 | HEALY JAMES | - | Sell | $1.81M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
CHRS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools